Fidelity Investments’s MapLight Therapeutics MPLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.7M Buy
1,541,940
+718,384
+87% +$13.5M ﹤0.01% 1970
2026
Q2
$29.5M Buy
823,556
+619,055
+303% +$17.8M ﹤0.01% 1724
2026
Q1
$4.16M Buy
204,501
+203,597
+22,522% +$3.64M ﹤0.01% 2362
2025
Q4
$15.9K Buy
+904
New +$15.1K ﹤0.01% 4566

Other funds holding MPLT

Fidelity Investments's MPLT Position: Q3 2026 in Review

Fidelity Investments increased its MapLight Therapeutics (MPLT) stake by 87% in Q3 2026, buying an estimated $13.5M and bringing the position to 1,541,940 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Fidelity Investments first reported a position in MPLT in Q4 2025 and has held it in 4 quarters since. The position peaked at $29.5M in Q2 2026. 60 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

  • Fidelity Investments held 1,541,940 shares of MapLight Therapeutics worth $15.7M as of Q3 2026.
  • Fidelity Investments bought 718,384 MapLight Therapeutics shares in Q3 2026, an estimated $13.5M.
  • MapLight Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1970 holding.
  • Fidelity Investments first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Fidelity Investments's MapLight Therapeutics position peaked at $29.5M in Q2 2026.
  • 60 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.